Early serum metabolomics distinguished delayed cerebral ischemia from non-DCI aneurysmal subarachnoid hemorrhage in a small retrospective cohort
A Simple Blood Test Could Predict a Dangerous Stroke Complication
This retrospective cohort study evaluated early serum metabolomics in 44 patients with aneurysmal subarachnoid hemorrhage (aSAH), comparing …
For patients who survive a burst brain aneurysm, a new discovery could help doctors see trouble coming days in advance and act to prevent fu…
Gut Metabolite Levels Associate with Outcomes After Aneurysmal Subarachnoid Hemorrhage
Can early blood tests predict brain injury after a severe brain bleed?
A prospective observational cohort of 80 patients with aneurysmal subarachnoid hemorrhage found lower levels of specific gut-derived metabol…
Low levels of specific gut chemicals in early blood tests may signal delayed brain injury after a severe brain bleed, offering a potential w…
Ensemble machine learning models show best discriminative performance for predicting DCI after aneurysmal SAH
Machine learning models show promise for predicting brain complications after aneurysm rupture
A systematic review and meta-analysis of 29 studies involving 10,000 patients with aneurysmal subarachnoid hemorrhage found that ensemble ma…
Machine learning models can predict dangerous brain complications after aneurysm rupture with moderate accuracy, but real-world testing is s…
Research across Stroke
Related studies from across the Stroke family.
Atractylenolide III shows neuroprotective effects in preclinical CNS disorder models
Atractylenolide III shows promise for brain and nerve injuries in lab models
This narrative review summarizes preclinical evidence that Atractylenolide III exerts neuroprotective effects in models of cognitive impairm…
Atractylenolide III looks like a helpful option for brain and nerve damage in early lab tests, though human trials are needed.
Case report details treatment of ANCA-associated vasculitis with Evans syndrome and cerebral infarction in a 72-year-old woman
Treatment stabilized some symptoms but not others in a single patient case
This case report describes a 72-year-old female with ANCA-associated vasculitis, Evans syndrome, and cerebral infarction treated with cortic…
A 72-year-old woman with complex blood vessel disease saw some health markers improve while others remained poor after specific treatments.
Review synthesizes neuroprotective potential of TCM metabolites using zebrafish models for neurological conditions
Traditional Chinese medicine metabolites protect brain cells from damage
This review examines the utility of Traditional Chinese medicine (TCM) metabolites for neurological conditions including Alzheimer's disease…
A review shows Traditional Chinese medicine metabolites protect brain cells through anti-inflammatory and anti-oxidative stress actions, off…
Evidence summary on glycemic variability management in ICU patients with cerebral infarction
ICU Guidelines Suggest Managing Blood Sugar Swings During Feeding
This evidence summary synthesizes 18 documents on glycemic variability management during enteral nutrition for adult ICU patients with cereb…
Guidelines advise managing blood sugar swings in ICU patients receiving tube feeding, noting that individual adjustments depend on local res…
Meta-analysis of preclinical studies suggests ligustrazine improves outcomes in cerebral ischemia-reperfusion injury
New data shows Ligustrazine helps brain recovery after stroke-like events in animals
This meta-analysis of preclinical animal studies evaluated ligustrazine for cerebral ischemia-reperfusion injury. Pooled results from 381 an…
New research suggests a specific plant compound could help the brain recover after blood flow is restored following a blockage
Review of SPMs for stroke notes promising neuroprotective effects with delivery limitations
Your Brain's Natural Healing Helpers Could Change Stroke Recovery
This review examines the role of exogenous administration of SPMs or their stable analogs in cerebral ischemia-reperfusion and stroke. The a…
After stroke, the brain's own healing chemicals might prevent lasting damage, but human trials haven't started yet.
Non-immersive virtual reality for upper limb motor function after chronic stroke
New Virtual Reality Training Helps Stroke Patients Regain Arm Movement
This randomized controlled trial in 26 patients with chronic middle cerebral artery stroke compared non-immersive virtual reality to convent…
A new virtual reality tool helps stroke patients regain arm movement skills in a way that standard therapy alone cannot match.
Narrative review discusses ischemia-reperfusion injury mechanisms and future therapeutic strategies
Heart and Brain Damage After Blood Flow Loss May Be Linked by Shared Cell Death Pathways
This narrative review addresses myocardial and cerebral ischemia-reperfusion injury.
This research reveals how heart and brain cells may die together through linked pathways, opening new doors for treatments that protect both…
Retrospective study of endovascular treatment for sICAS shows no significant difference in 30-day stroke or death between early and delayed groups
Timing of treatment did not change stroke risk for patients with brain vessel blockages
This retrospective single-center study analyzed 174 consecutive patients with symptomatic intracranial atherosclerotic stenosis undergoing i…
For people with blocked brain vessels, getting endovascular treatment early versus later did not significantly lower the risk of stroke or d…
First-line suction aspiration versus combination technique for acute cerebral infarction in a multicenter trial
Imagine waking up unable to move one side of your body. This sudden loss of control is a stroke. Every minute counts when a blood vessel in the brain is blocked. Doctors race to open the vessel and save brain tissue. Time is the most important factor in recovery
This prospective, randomized, multicenter, noninferiority, open-label trial enrolled 1136 patients with acute cerebral infarction amenable t…
Strokes are a leading cause of disability worldwide.
Narrative review examines resveratrol in Alzheimer's, Parkinson's, MS, and cerebral ischemia with noted limitations
This Common Food Compound May Shield Your Brain From Damage
This narrative review evaluates resveratrol across Alzheimer's disease, Parkinson's disease, multiple sclerosis, and cerebral ischemia.
A natural compound found in berries shows promise for protecting brain cells, but human proof is still missing.
Higher CRP and D-dimer levels associated with cerebral infarction in children with Mycoplasma pneumoniae pneumonia
High Fever Warning: Two Blood Tests Spot Stroke Risk in Kids
This retrospective cohort study included 2,947 children diagnosed with Mycoplasma pneumoniae pneumonia.
Two simple blood tests can spot stroke risk in kids with pneumonia before brain damage happens, helping doctors catch rare cases early.
Questions about Delayed Cerebral Ischemia
Can early serum tests help predict delayed cerebral ischemia before symptoms start?
Early blood tests for metabolites like calprotectin, melatonin, and specific gut-derived compounds can help predict delayed cerebral ischemia (DCI) before symptoms appear, though combining these with other data works best.
Full answer →Can blood tests tell me if I will get delayed cerebral ischemia?
Current blood tests can show patterns that separate patients who develop delayed cerebral ischemia from those who do not, but no single standard test exists yet for predicting this condition.
Full answer →